A Study of TAK-951 in Healthy Adults

NCT06610279 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

48

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated based on the Sponsor's decision attributed to the benefit-risk profile derived from the Part 1 data of this study.

Conditions

Healthy Volunteers

Interventions

DRUG: TAK-951
DRUG: Placebo

Sponsor

Takeda